Theravance Biopharma, Inc. (TBPH)
20.48
+0.90
(+4.60%)
USD |
NASDAQ |
Feb 06, 16:00
20.46
-0.02
(-0.10%)
After-Hours: 20:00
Theravance Biopharma SG&A Expense (TTM) : 75.94M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Corcept Therapeutics, Inc. | 401.86M |
| Nektar Therapeutics | 74.62M |
| Innoviva, Inc. | 112.52M |
| Oramed Pharmaceuticals, Inc. | 7.17M |
| Skye Bioscience, Inc. | 16.93M |